Sei Investments CO Neogenomics Inc Transaction History

Sei Investments CO

  • $69 Billion
  • Q2 2024

A detailed history of Sei Investments CO transactions in Neogenomics Inc stock. As of the latest transaction made, Sei Investments CO holds 263,761 shares of NEO stock, worth $3.82 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
263,761
Previous 104,411 152.62%
Holding current value
$3.82 Million
Previous $1.64 Million 122.91%
% of portfolio
0.01%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$13.01 - $15.77 $2.07 Million - $2.51 Million
159,350 Added 152.62%
263,761 $3.66 Million
Q1 2024

May 07, 2024
SELL
$14.06 - $16.79 $72,254 - $86,283
-5,139 Reduced 4.69%
104,411 $1.64 Million
Q4 2023

Feb 14, 2024
BUY
$11.67 - $20.73 $248,209 - $440,906
21,269 Added 24.09%
109,550 $1.77 Million
Q3 2023

Nov 14, 2023
SELL
$12.15 - $17.85 $59,036 - $86,733
-4,859 Reduced 5.22%
88,281 $1.09 Million
Q2 2023

Aug 11, 2023
SELL
$14.1 - $19.83 $277,036 - $389,619
-19,648 Reduced 17.42%
93,140 $1.5 Million
Q1 2023

May 12, 2023
BUY
$9.09 - $19.45 $633,772 - $1.36 Million
69,722 Added 161.9%
112,788 $1.96 Million
Q4 2022

Feb 10, 2023
SELL
$6.45 - $12.07 $133,211 - $249,281
-20,653 Reduced 32.41%
43,066 $397,000
Q3 2022

Nov 14, 2022
SELL
$7.86 - $12.91 $19,099 - $31,371
-2,430 Reduced 3.67%
63,719 $548,000
Q2 2022

Aug 15, 2022
SELL
$7.06 - $13.97 $1.03 Million - $2.04 Million
-145,728 Reduced 68.78%
66,149 $539,000
Q1 2022

May 13, 2022
SELL
$12.15 - $35.28 $935,622 - $2.72 Million
-77,006 Reduced 26.66%
211,877 $2.57 Million
Q4 2021

Feb 14, 2022
BUY
$30.49 - $48.49 $2.35 Million - $3.74 Million
77,125 Added 36.42%
288,883 $9.86 Million
Q3 2021

Nov 12, 2021
BUY
$41.66 - $52.52 $5.15 Million - $6.5 Million
123,734 Added 140.57%
211,758 $10.2 Million
Q2 2021

Aug 06, 2021
SELL
$36.62 - $51.69 $526,705 - $743,457
-14,383 Reduced 14.04%
88,024 $3.98 Million
Q1 2021

May 12, 2021
SELL
$41.56 - $59.88 $345,238 - $497,423
-8,307 Reduced 7.5%
102,407 $5.06 Million
Q4 2020

Feb 08, 2021
BUY
$36.08 - $56.47 $931,657 - $1.46 Million
25,822 Added 30.42%
110,714 $5.96 Million
Q3 2020

Dec 04, 2020
SELL
$33.26 - $40.48 $11,341 - $13,803
-341 Reduced 0.4%
84,892 $3.13 Million
Q3 2020

Nov 06, 2020
SELL
$33.26 - $40.48 $13,902 - $16,920
-418 Reduced 0.49%
85,233 $3.15 Million
Q2 2020

Aug 17, 2020
BUY
$24.21 - $31.02 $1.55 Million - $1.98 Million
63,940 Added 294.51%
85,651 $2.65 Million
Q2 2020

Aug 11, 2020
SELL
$24.21 - $31.02 $2.02 Million - $2.59 Million
-83,341 Reduced 79.33%
21,711 $638,000
Q1 2020

May 14, 2020
BUY
$20.5 - $34.53 $1.18 Million - $1.99 Million
57,605 Added 121.41%
105,052 $2.9 Million
Q4 2019

Feb 06, 2020
BUY
$18.96 - $29.84 $400,852 - $630,877
21,142 Added 80.37%
47,447 $1.39 Million
Q3 2019

Nov 12, 2019
SELL
$19.12 - $26.24 $661,857 - $908,323
-34,616 Reduced 56.82%
26,305 $502,000
Q2 2019

Aug 14, 2019
SELL
$19.57 - $24.1 $270,242 - $332,796
-13,809 Reduced 18.48%
60,921 $1.34 Million
Q1 2019

May 15, 2019
BUY
$12.14 - $20.46 $81,823 - $137,900
6,740 Added 9.91%
74,730 $1.53 Million
Q4 2018

Feb 13, 2019
BUY
$11.24 - $18.5 $659,518 - $1.09 Million
58,676 Added 629.98%
67,990 $875,000
Q3 2018

Nov 08, 2018
SELL
$12.5 - $15.38 $610,337 - $750,959
-48,827 Reduced 83.98%
9,314 $144,000
Q2 2018

Aug 03, 2018
BUY
$7.99 - $14.05 $72,117 - $126,815
9,026 Added 18.38%
58,141 $762,000
Q1 2018

May 11, 2018
BUY
$7.23 - $8.76 $109,838 - $133,081
15,192 Added 44.78%
49,115 $401,000
Q4 2017

Feb 08, 2018
SELL
$8.02 - $11.18 $25,647 - $35,753
-3,198 Reduced 8.62%
33,923 $301,000
Q3 2017

Nov 06, 2017
BUY
$9.11 - $11.26 $338,172 - $417,982
37,121
37,121 $413,000

Others Institutions Holding NEO

# of Institutions
278
Shares Held
127M
Call Options Held
581K
Put Options Held
107K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.82B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email